<code id='08EAC139E7'></code><style id='08EAC139E7'></style>
    • <acronym id='08EAC139E7'></acronym>
      <center id='08EAC139E7'><center id='08EAC139E7'><tfoot id='08EAC139E7'></tfoot></center><abbr id='08EAC139E7'><dir id='08EAC139E7'><tfoot id='08EAC139E7'></tfoot><noframes id='08EAC139E7'>

    • <optgroup id='08EAC139E7'><strike id='08EAC139E7'><sup id='08EAC139E7'></sup></strike><code id='08EAC139E7'></code></optgroup>
        1. <b id='08EAC139E7'><label id='08EAC139E7'><select id='08EAC139E7'><dt id='08EAC139E7'><span id='08EAC139E7'></span></dt></select></label></b><u id='08EAC139E7'></u>
          <i id='08EAC139E7'><strike id='08EAC139E7'><tt id='08EAC139E7'><pre id='08EAC139E7'></pre></tt></strike></i>

          hotspot

          hotspot

          author:focus    Page View:345
          The Dr. Gary B. and Pamela S. Williams Tower in Summa Health System's Akron Campus
          Summa Health

          General Catalysts’s grand vision for a venture capital-owned hospital system seamlessly blending AI and tech into everyday appointments and rewarding staff for keeping patients healthy might sound alluring. But the firm’s bold experiment is facing hurdles even before it has started as the community served by the health system it hopes to buy is pushing back.

          The Health Assurance Transformation Corp., a General Catalyst entity known as HATCo, unveiled plans last month to acquire Akron safety net provider Summa Health. But since the announcement, residents and local officials have raised questions about who the deal benefits, and who gets left behind.

          advertisement

          On Thursday, the Mayor of Akron plans to press HATCo’s chief executive, Marc Harrison, who previously led Intermountain Health, on whether his plan is a profit play or a longer-term investment in the community. At the forefront are citizens’ concerns that the deal will drive up costs, eliminate jobs, reduce the quality of care or even shutter one of just two major hospital systems in the area, about a fifth of whose patients are on Medicaid.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          BridgeBio heart drug succeeds in pivotal study
          BridgeBio heart drug succeeds in pivotal study

          AdobeAdrugdevelopedbythebiotechfirmBridgeBiototreatanincreasinglycommonheartconditionsucceededinitsm

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          A look at other Americans who have crossed into North Korea over the years

          FILE-MatthewMiller,aU.S.citizen,sitsonthedockattheSupremeCourtduringhistrialinPyongyang,NorthKoreaon